Sudip Datta

Dr. Sudip Datta is the chair of the Finance Department and Professor of Finance. He also holds the Missouri Bankers Chair. 

Dr. Datta’s research covers a wide variety of areas related to finance, such as, mergers and acquisitions, LBOs/RLBOs, divestitures, executive compensation, gender-based decision-making, initial public offerings of debt securities, capital structure decisions and debt structure choice, insider trading, corporate bankruptcy, earnings management, analysts forecasts, corporate pension funding decisions, internal corporate restructuring, and corporate downsizing. He has published several articles in top finance and management journals, including The Journal of Finance, Journal of Financial Economics, Journal of Financial and Quantitative Analysis, Journal of Business, Journal of Financial Intermediation, Financial Management, Journal of Banking and Finance, Journal of Financial Stability, Finance Research Letters, Journal of Applied Corporate Finance, Strategic Management Journal, and the Harvard Business Review. 

Dr. Datta serves on the editorial boards of:Journal of Banking and Finance, Journal of Financial Stability, Journal of Business Valuation and Economic Loss Analysis, International Journal of Managerial Finance, Corporate Ownership and Control, International Review of Banking and Financial Studies, Corporate Ownership and Organizational Behavior Review, and Review of Business. Dr. Datta is a regular commentator in radio and print media providing in-depth commentary on a variety of financial topics. Media appearances include: The Wall Street Journal, Investor's Business Daily, The Washington Post, CFO magazine, The Detroit News, Detroit Free Press, Worcester Telegraph, Economic Intuition, The Bowne Review of CFOs and Investment Bankers, CFA Digest, The Clarion Ledger, WDET Detroit Public Radio, among others. Dr. Datta has consulting experience and expertise in business valuation, estimation of financial damages/forgone earnings due to job related injuries, valuation of executive and employee stock options, valuation of shareholder damages due to stock price manipulation, insider-trading related damages, private company valuation, mergers/acquisitions, initial public offerings, and seasoned offerings.